Lang M - Search Results

1

Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds.

Furet P, Batzl C, Bhatnagar A, Francotte E, Rihs G, Lang M. Furet P, et al. Among authors: lang m. J Med Chem. 1993 May 14;36(10):1393-400. doi: 10.1021/jm00062a012. J Med Chem. 1993. PMID: 8496907

2

Structure-activity relationships and binding model of novel aromatase inhibitors.

Lang M, Batzl C, Furet P, Bowman R, Häusler A, Bhatnagar AS. Lang M, et al. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):421-8. doi: 10.1016/0960-0760(93)90245-r. J Steroid Biochem Mol Biol. 1993. PMID: 8476755

3

Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.

Imbach P, Lang M, García-Echeverría C, Guagnano V, Noorani M, Roesel J, Bitsch F, Rihs G, Furet P. Imbach P, et al. Among authors: lang m. Bioorg Med Chem Lett. 2007 Jan 15;17(2):358-62. doi: 10.1016/j.bmcl.2006.10.047. Epub 2006 Oct 24. Bioorg Med Chem Lett. 2007. PMID: 17095212

4

New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.

Stauffer F, Furet P, Floersheimer A, Lang M. Stauffer F, et al. Among authors: lang m. Bioorg Med Chem Lett. 2012 Mar 1;22(5):1860-3. doi: 10.1016/j.bmcl.2012.01.076. Epub 2012 Jan 28. Bioorg Med Chem Lett. 2012. PMID: 22335894

5

Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.

Schieweck K, Bhatnagar AS, Batzl C, Lang M. Schieweck K, et al. Among authors: lang m. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):633-6. doi: 10.1016/0960-0760(93)90270-7. J Steroid Biochem Mol Biol. 1993. PMID: 8476774

6

Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.

Traxler P, Bold G, Frei J, Lang M, Lydon N, Mett H, Buchdunger E, Meyer T, Mueller M, Furet P. Traxler P, et al. Among authors: lang m. J Med Chem. 1997 Oct 24;40(22):3601-16. doi: 10.1021/jm970124v. J Med Chem. 1997. PMID: 9357527

7

Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design.

Furet P, Imbach P, Fürst P, Lang M, Noorani M, Zimmermann J, García-Echeverria C. Furet P, et al. Among authors: lang m. Bioorg Med Chem Lett. 2001 May 21;11(10):1321-4. doi: 10.1016/s0960-894x(01)00206-2. Bioorg Med Chem Lett. 2001. PMID: 11392546

8

Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.

Furet P, Imbach P, Fuerst P, Lang M, Noorani M, Zimmermann J, García-Echeverría C. Furet P, et al. Among authors: lang m. Bioorg Med Chem Lett. 2002 May 20;12(10):1331-4. doi: 10.1016/s0960-894x(02)00178-6. Bioorg Med Chem Lett. 2002. PMID: 11992770

9

Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.

Furet P, Imbach P, Noorani M, Koeppler J, Laumen K, Lang M, Guagnano V, Fuerst P, Roesel J, Zimmermann J, García-Echeverría C. Furet P, et al. Among authors: lang m. J Med Chem. 2004 Sep 23;47(20):4810-3. doi: 10.1021/jm049660v. J Med Chem. 2004. PMID: 15369383 Free article.

10

Entry into a new class of protein kinase inhibitors by pseudo ring design.

Furet P, Caravatti G, Guagnano V, Lang M, Meyer T, Schoepfer J. Furet P, et al. Among authors: lang m. Bioorg Med Chem Lett. 2008 Feb 1;18(3):897-900. doi: 10.1016/j.bmcl.2007.12.041. Epub 2008 Jan 14. Bioorg Med Chem Lett. 2008. PMID: 18248988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,135 results

Search Page

Filters